ABSTRACT PURPOSE: To compare the long-term results (9 years) of LASIK in one eye and phakic intraocular lens (implantable contact lens [ICL]) implantation in the fellow eye of the same patient.
RESULTS: At 9 years postoperatively, the mean spherical equivalent refraction was Ϫ1.00 in the eye with the ICL and Ϫ1.75 D in the eye that underwent LASIK. During the fi rst 6 postoperative months in the LASIK eye, refraction regressed, but remained stable during the remainder of follow-up. Uncorrected visual acuity was 20/25 in the eye with the ICL and 20/30 in the LASIK eye, whereas best spectacle-corrected visual acuity was 20/20 in both eyes. Less night vision problems (glare and halos) were experienced in the eye with the ICL compared to the LASIK eye. Although the patient initially preferred the LASIK procedure, at last follow-up 9 years postoperatively, increased overall satisfaction was reported for the eye with the ICL compared to the LASIK eye.
CONCLUSIONS: Nine years after treatment of high myopia with the ICL and LASIK in the same patient, better quality of vision, stability, and satisfaction score were achieved in the eye with the ICL compared to the eye that had undergone LASIK. No longterm sight-threatening complications were found during followup. [J Refract Surg. 2007 ;23: 935-937.] M any different parameters must be considered when deciding whether a patient is a good candidate for refractive surgery. Refractive error, patient age, corneal pachymetry and topography, scotopic pupil size, and fundus examination as well as the patient's needs and psychological profi le are the main criteria for choosing the proper treatment.
For high myopic corrections, surgeons have to choose, according to the patient's preoperative profi le, between keratorefractive (surface or intrastromal) and intraocular procedures (phakic intraocular lens [IOL] implantation or clear lens extraction). Possible complications in high myopic corrections after keratorefractive techniques include corneal ectasia, myopic regression, poor quality of vision in scotopic conditions, and haze, 1 whereas intraocular procedures, despite better optical results, 2 are more invasive and may result in endothelial cell loss and elevated intraocular pressure. 3, 4 Few comparative studies between implantable contact lens (ICL) and LASIK exist. [5] [6] [7] [8] [9] Two prospective, randomized clinical trials have been reported 8, 9 ; however, follow-up was р3 years. As long-term evaluation is essential for any procedure, we report 9-year follow-up in a patient who participated in a prospective, randomized, comparative clinical study of LASIK and phakic IOL implantation for the correction of high myopia.
CASE REPORT
A 21-year-old woman presented for refractive surgery evaluation in 1997. Uncorrected visual acuity (UCVA) was count fi ngers in both eyes. Preoperative best spectacle-corrected visual acuity (BSCVA) was 20/20 with refraction of Ϫ9.25 Ϫ0.50 ϫ 85 in the right eye and 20/20 with refraction of Ϫ9.50 Ϫ0.50 ϫ 125 in the left eye. Scotopic pupil size was 6 mm in both eyes. Central corneal thickness was 496 µm in the right eye and 506 µm in the left eye. Intraocular pressure was 11 mmHg in both eyes. The patient had no family history of keratoconus. Keratometry was 42.29/43.15 in the right eye and 42.39/43.32 in the left eye (Fig) . Ophthalmic examination found no anterior or posterior segment abnormality.
The patient was included in a prospective, randomized, comparative clinical study between LASIK and phakic refractive lens implantation. The patient was fully informed of the possible intra-and postoperative complications and gave written consent in accordance with institutional guidelines and the Declaration of Helsinki.
On July 27, 1997, the patient underwent LASIK in the left eye and 1 month later underwent ICL implantation (posterior chamber hydrogel collagen plate phakic IOL; STAAR Collamer ICL [STAAR Surgical AG,
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Nidau, Switzerland]; ICM 120V2, size 12 mm) in the right eye. The procedures were randomized according to a coin fl ip.
Laser in situ keratomileusis was performed with the MEL 60 excimer laser (Aesculap Meditec, Heroldsberg, Germany) after a nasally hinged fl ap of 139 µm (intraoperative pachymetry) was made by the Flapmaker microkeratome (Refractive Technologies Inc, Cleveland, Ohio). The attempted correction was Ϫ9.50 D at the 5-mm optical zone, with no transition zone (estimated maximum ablation depth 87 µm), leaving a residual corneal stromal bed thickness of 280 µm.
Lens power calculations were performed by STAAR Surgical AG on the basis of the following variables: 1) manifest and cycloplegic refractions for a vertex distance of 12.0 mm; 2) keratometry; 3) corneal thickness; and 4) anterior chamber depth. The size of the ICL was chosen by STAAR according to the patient's horizontal corneal diameter (white-to-white) measured with a caliper.
Procedures in both eyes were uneventful. No statistically signifi cant alterations were found regarding the visual acuity or refraction in the ICL eye during follow-up. Best spectacle-corrected visual acuity was 20/20 in both eyes at all postoperative examinations (no gain or loss of Snellen lines). Slit-lamp and fundus examinations of both eyes were unremarkable. The corneal topographic appearance revealed anatomical stability in both eyes (see Fig) .
Binocular vision was not affected by the different surgical procedures (keratorefractive and intraocular). At last follow-up 9 years postoperatively, the patient reported increased overall satisfaction with the eye implanted with the ICL compared to the LASIK eye, Reports due to superior UCVA, stability, and less night vision problems (glare and halos).
DISCUSSION
Laser in situ keratomileusis and phakic refractive IOL implantation are the most commonly used procedures for the correction of large degrees of ametropia, especially in young patients. In high myopic corrections (Ͼ10.00 D), predictability, effi cacy, stability, and safety of LASIK has been reported to be low. 10 Moreover the quality of vision is poor due to the need for smaller attempted optical zones, 5 the signifi cant decrease in photopic or mesopic contrast sensitivity, 11, 12 and the increase of spherical aberration 3 postoperatively. On the contrary, phakic refractive IOL implantation, despite the potential damage to endothelial cells, 3, 4 is a theoretically reversible technique, does not affect the natural prolate shape of the cornea, and contrast sensitivity can be preserved or even improved. 11, 12 In previous comparative studies of the two procedures with follow-up of up to 3 years, 8, 9 eyes that underwent phakic refractive IOL implantation had better UCVA and more eyes gained BSCVA lines compared with eyes that underwent LASIK. In this report, better UCVA and stability of residual refractive error with less glare and halos were noted in the eye with the ICL compared to the eye treated with LASIK. The more intense night vision problems in the LASIK eye can be explained by the small attempted optical zone of 5 mm (smaller than the patient's scotopic pupil size) and the absence of a transition zone. Overall, the patient preferred the ICL eye due to better stability and quality of vision.
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were observed, and confocal microscopy revealed a regenerated nerve plexus and normal cornea. However, increased scattering and presence of debris were observed at the fl ap interface even after 15 years. Despite moderate predictability (residual refractive error) and small optical zone, the patient was satisfi ed with fi nal outcome.
CONCLUSIONS:
One of the fi rst LASIK-treated patients was presented 15 years after surgery. LASIK in this patient had low predictability, although refractive and topographic stability occurred after the sixth postoperative month. No long-term, sight-threatening complications were identifi ed during follow-up. Although LASIK is a more invasive procedure than photorefractive keratectomy (PRK) and the cornea is exposed to more possible risks (eg, fl ap-related complications and ectasia), 2, 3 it changed the trends in refractive surgery and has become the most popular refractive technique for the correction of ametropia 4 over the past decade.
To our knowledge, there are few long-term postoperative LASIK studies, and none exceed 6 years' followup. [5] [6] [7] We present one of the fi rst LASIK-treated patients who participated in the fi rst worldwide LASIK trial in Crete, Greece, 15 years after unilateral surgery using a fi rst-generation microkeratome and excimer laser.
CASE REPORT
A 40-year-old woman underwent LASIK in the left eye for myopia in July 1991. Ocular history was unremarkable. Preoperative examination included slit-lamp microscopy, uncorrected visual acuity (UCVA), Snellen best spectacle-corrected visual acuity (BSCVA), manifest and cycloplegic refractions, intraocular pressure (IOP), corneal topography (Corneal Analysis System version 2.104; EyeSys Laboratories Inc, Houston, Tex), and optical pachymetry of the central cornea. Uncorrected visual acuity was counting fi ngers in both eyes. Best spectacle-corrected visual acuity was 20/32 with Ϫ7.00 Ϫ1.25 ϫ 149° in the right eye and 20/100 with Ϫ8.75 Ϫ3.75 ϫ 025° in the left eye. Central keratometric measurement was 43.88/44.95 D and 43.75/46.25 D in the right and left eye, respectively. Central corneal thickness was 534 µm and 530 µm in the right and the left eye, respectively.
The patient was fully informed regarding the experimental nature of the procedure, as well as possible intra-and postoperative complications, and gave written informed consent in accordance with institutional guidelines and the Declaration of Helsinki.
The eye was anesthetized with topical oxybuprocaine hydrochloride 4 mg/mL eyedrops (Novesin 0.4%; CibaVision, Embrach, Switzerland [formerly Dispersa AG, Hettlingen, Switzerland]), one drop every 5 minutes for a total of three drops before surgery. Peribulbar anesthesia was then administered (2 to 4 cc lidocaine hydrochloride 20 mg/mL [Xylocaine 2%; AstraZeneca, Sodertalje, Sweden]). A Barraquer eyelid speculum (Katena Products Inc, Denville, NJ) was placed, and the eye was cleaned with normal saline. A nasally based, 150-µm thick corneal fl ap was made with a Draeger's lamellar rotor keratome (Storz Instruments GmbH, Heidelberg, Germany) using a 0.15-mm spacer. This rotor keratome was semiautomatic and operates with a rotational mode of its blade. During microkeratome suction fi xation, IOP was raised to 60 mmHg.
Following formation of the corneal fl ap, the microkeratome with its suction ring was removed and the fl ap refl ected nasally. The corneal bed was ablated with a 193-nm excimer laser (MEL 60; Carl Zeiss Meditec, Heroldsberg, Germany), beam fl uence at the cornea of 220 mJ/cm 2 and a fi ring rate of 20 Hz, with a 5-0 mm ablation zone. We used the PRK algorithm that was programmed with the machine. No astigmatic correction was performed, and attempted correction was 10.00 D (estimated maximum ablation depth of 83 µm). The automated 4.9-mm diameter, computer-controlled, contracting iris diaphragm of the unit, with its incorporated suction ring, was placed on the corneal bed and the intended correction was entered into the module. Before ablation, beam quality was checked on photographic paper.
After excimer laser ablation, the bed was irrigated with normal saline for aproximately 5 to 10 seconds. The corneal bed and inner surface of the fl ap were dried with an air pump, and the corneal fl ap was refl ected back to its original position. At the end of the surgery, 3 mg tobramycin 0.3% and 1 mg dexamethasone 0.1% (Tobradex; Alcon Laboratories Inc, Ft Worth, Tex) and tropicamide 1 mg/mL eye drops (Mydriaticum; Novartis Ophthalmics AG, Basel, Switzerland [formerly Dispersa]) were instilled. One milliliter of 40 mg of methylprednisolone acetate was injected into the sub-Tenon's space, and a therapeutic bandage soft contact lens was used for 48 hours after surgery. The entire procedure was performed under the excimer laser surgical microscope.
The patient was examined every 24 hours for the next 5 days. The patient received antibiotic/steroid combination eye drops 4 times a day for 4 weeks. The early postoperative course was uneventful.
Follow-up was scheduled at 1 day, 2 weeks, 1, 3, and 6 months, and 1 year postoperatively. Full refraction, slitlamp, and topographic examination (Corneal Analysis System for the fi rst postoperative year and last follow-up with the Technomed C-Scan [Technomed GmbH, Baesweilec, Germany]) were performed at each visit.
RESULTS
Six months postoperatively, UCVA was counting fi ngers and BSCVA was 20/80 with Ϫ3.75 Ϫ3.00 ϫ 020° in the left eye. Manifest refraction, UCVA, BSCVA, and topographic fi ndings were stable during the next 6 months. Fifteen years later, UCVA was counting fi ngers in both eyes. Best spectacle-corrected visual acuity was 20/32 with Ϫ7.75 Ϫ1.50 ϫ 130° in the right eye and 20/80 with Ϫ4.25 Ϫ2.75 ϫ 010° in the left eye, and topographic stability was observed (Figs 1 and 2) .
Confocal microscopy analysis was performed with a modifi ed confocal scanning laser ophthalmoscope (HRT II Rostock Cornea Module; Heidelberg Engineering Inc, Vista, Calif). Qualitative evaluation of the images was performed with special attention directed at the subepithelial nerve plexus and fl ap interface. Corneal images revealed a normal epithelium with fl at superfi cial cells, polygonal intermediate cells, and cylindrical basal cells. Images of the subbasal and subepithelial nerve plexus exhibited a regenerated nerve plexus that appeared normal with slightly increased tortuosity (Fig 3A) . Keratocytes' bright nuclei against a dark background were observed just anterior to the fl ap interface (Fig 3B) , whereas keratocyte activation, Reports increased scattering, and highly refl ective particles were observed at the fl ap interface (Fig 3C) . Keratocyte density at the anterior fl ap seemed higher compared to the deeper stromal layers.
On a current overall satisfaction scale of 1 to 5, the patient was considered to be happy with the results (score of 4).
DISCUSSION
Fifteen years have passed since the fi rst published case series of human eyes treated with LASIK, 1 although long-term follow-up studies of LASIK-treated eyes do not exceed observation over 6 years. 5 During these years, an impressive improvement in microkeratome and excimer laser technology has led to significant decrease in intraoperative and early postoperative complications. Despite these improvements, long-term postoperative complications, with a major interest in the possible effects of such an invasive technique on ocular structures, has not yet been investigated.
In the present case report, long-term complications were not observed. Refractive and topographic stability were achieved 6 months after LASIK treatment. Previous long-term follow-up studies of myopic LASIK have shown moderate refractive predictability and stability in attempted higher corrections. [5] [6] [7] Similarly, we found moderate predictability in the refractive outcome with a trend for refractive and topographic stability after the sixth postoperative month despite the large attempted correction (Ϫ10.00 D) and estimated residual corneal stroma (Ͻ300 µm). Furthermore, increased scattering and presence of debris was observed at the fl ap interface even after 15 years.
Unexpectedly, the patient was satisfi ed with the final outcome despite considerable residual compound myopic astigmatism. We believe patients with high degrees of ametropia and amblyopia (such as the patient in the current study) are more receptive to such outcomes.
To our knowledge, this is the longest (15 years) LASIK follow-up case report in the literature. Late postoperative complications related to the surgery were not observed; conversely, refractive stability was observed after the sixth postoperative month.
Bilateral Keratectasia After Photorefractive Keratectomy
Alejandro Navas, MD; Enrique Ariza, MD; Alberto Haber, MD; Salomón Fermón, MD; Roberto Velázquez, MD; Raúl Suárez, MD ABSTRACT PURPOSE: To report the clinical features, management, and outcome of a patient who developed bilateral ectasia after photorefractive keratectomy (PRK).
METHODS:
Case report of a 35-year-old man who underwent bilateral PRK. Preoperative uncorrected visual acuity was 20/200 in the right eye and 20/100 in the left eye. The patient's history was unremarkable and he denied a family history of ocular disorders.
RESULTS:
Two weeks after surgery, the patient presented with loss of visual acuity in both eyes. Uncorrected visual acuity was 20/80 in the right eye and 20/200 in the left eye. Objective refraction could not be obtained. Slit-lamp microscopy showed corneal thinning in both eyes. After examining the patient's family, his sister was found to have clinical and topographic keratoconus.
CONCLUSIONS: Ectasia is a rare complication of PRK. We report the occurrence of bilateral ectasia after PRK in a patient with asymmetric bowtie topographies. We recommend that refractive surgery, even surface techniques such as PRK, be avoided in patients with a family history of keratoconus. T he fi rst case of ectasia development after LASIK was reported in 1998, and it was not until after 2000 that a signifi cant number of cases had been described. 1 Keratectasia after excimer laser is a potentially devastating complication with visual morbidity that, in some cases, requires penetrating keratoplasty. 2, 3 The etiology and biomechanical changes that induce keratectasia after refractive surgery are unknown. 4 Possible risk factors for the development of ectasia following excimer laser have been identifi ed in the literature 2, 5, 6 and include high myopia, reduced preoperative corneal thickness, reduced residual stromal bed after laser ablation, and asymmetrical corneal steepening (forme fruste keratoconus), but none of these characteristics defi nitively predict development of ectasia. Ectasia can develop in eyes with no identifiable risk factors. 2, 5, 6 Holland et al 7 reported cases of ectasia after photorefractive keratectomy (PRK) due to retreatment or unrecognized keratoconus.
Malecaze et al 8 recently reported a case of corneal ectasia after PRK in a patient with forme fruste keratoconus. Koch 9 suggested that data be reported for patients who develop keratectasia after excimer laser; therefore, we report a patient who developed bilateral corneal ectasia after uneventful PRK with asymmetric bowtie topography and suspicion for forme fruste keratoconus in the right eye. Reports and Ϫ3.00 Ϫ2.00 ϫ 165 in the left eye. The ablation zone diameter was 5.0 mm and 5.5 mm, respectively. The calculated total ablation depth was 67 µm in the right eye and 70 µm in the left eye. After 5 days, the epithelium was fully recovered and the soft contact lenses were removed. Uncorrected visual acuity was 20/50 bilaterally.
CASE REPORT
Two weeks after surgery, the patient experienced loss in visual acuity in both eyes. Uncorrected visual acuity was 20/80 in the right eye and 20/200 in the left eye. Objective refraction was impossible to obtain. Slit-lamp examination showed corneal thinning in both eyes. The patient was required to wear rigid contact lenses to achieve a fi nal BSCVA of 20/25 in both eyes.
Six months after surgery, topographic fi ndings were consistent with the diagnosis of corneal ectasia after PRK. Nine months after PRK, UCVA was 20/70 in the right eye and 20/80 in the left eye. We found a scissoring refl ex on retinoscopy, corneal thinning, and mild prominent corneal nerves in both eyes. Both topographic and clinical fi ndings (Figs 3 and 4) persisted with the diagnosis of keratectasia in both eyes. Best spectacle-corrected visual acuity with rigid contact lenses was 20/20 bilaterally.
DISCUSSION
Corneal ectasia after PRK is extremely rare. In our case, the patient did not have tangible risk factors except for asymmetric bowtie topographies.
Ectasia after LASIK has been described to occur within weeks and up to 45 months after the primary surgery. 10 Our patient presented only 2 weeks after surgery with fi ndings consistent with ectasia. One possibility for ectasia-like fi ndings is that the healing of corneal epithelium during the early postoperative period may result in an artifi cial and temporary hyperfl attening of the corneal contour 11 ; unfortunately, we did confi rm the diagnosis of ectasia after PRK in our patient.
Photorefractive keratectomy has proven to be a safe, simple, and effective procedure to correct low to moderate myopia, and with proper patient selection can be considered safer compared to other refractive proce- Reports dures. 12, 13 Alio et al 12 reported few complications after PRK in 3000 eyes. Over the past few years, mitomycin C treatments have gained popularity to reduce haze and allow greater surface ablations. 14, 15 Using our case as an example, refractive surgeons should be aware of the possibility of corneal ectasia occurrence in low myopia, low ablation, and with enough residual stromal bed after ablation even when a corneal fl ap is not performed.
After clinical ectasia presented in our patient, we further questioned him regarding other risk factors. He advised he was a habitual eye rubber in both eyes since childhood. As Comaish et al 6 proposed, surgeons should be aware of the potential for development of progressive keratectasia after excimer laser in chronic eye rubbers.
Binder 10 recommends investigating clinical or topographic evidence of keratoconus or forme fruste keratoconus in a family history before evaluating the ablation used. After the ectasia occurred, we examined the patient's family and found a sister with clinical and topographic keratoconus. Some surgeons avoid performing refractive surgery in patients with a family history of keratoconus. As proposed by Rabinowitz, 16 we considered family history an important risk factor in the algorithm to prevent ectasia. Therefore, we recommend avoiding refractive surgery, even surface techniques such as PRK, in patients with a family history of keratoconus.
